Identification of a synthetic peptide inducing cross-reactive antibodies binding to Rhipicephalus (Boophilus) decoloratus, Rhipicephalus (Boophilus) microplus, Hyalomma anatolicum anatolicum and Rhipicephalus appendiculatus BM86 homologues
The BM86 antigen, originally identified in Rhipicephalus (Boophilus) microplus, is the basis of the only commercialized anti-tick vaccine. The long-term goal of our study is to improve BM86 based vaccines by induction of high levels of tick gut binding antibodies that are also cross-reactive with a...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Journal Article |
| Language: | Inglés |
| Published: |
Elsevier
2009
|
| Online Access: | https://hdl.handle.net/10568/381 |
Similar Items: Identification of a synthetic peptide inducing cross-reactive antibodies binding to Rhipicephalus (Boophilus) decoloratus, Rhipicephalus (Boophilus) microplus, Hyalomma anatolicum anatolicum and Rhipicephalus appendiculatus BM86 homologues
- Vaccination of cattle with TickGARD induces cross-reactive antibodies binding to conserved linear peptides of Bm86 homologues in Boophilus decoloratus
- Isolation, recombinant expression and characterization of polymorphism of BM86 vaccine antigen homologues from rhipicephalus appendiculatus.
- Differential transcription of two highly divergent gut-expressed Bm86 antigen gene homologues in the tick Rhipicephalus appendiculatus (Acari: Ixodida)
- Resistance of the cattle tick Rhipicephalus (Boophilus) microplus to fluazuron in Argentina
- Eprinomectin accumulation in Rhipicephalus (Boophilus) microplus : pharmacokinetic and efficacy assessment
- Resistance of the cattle tick Rhipicephalus (Boophilus) microplus to ivermectin in Argentina